Aurora Cannabis Inc. ACB

Competitive advantage analysis · healthcare

Corporate Default
Overall moat score
58/100
Moderate

Ranked against 90 peers in Drug Manufacturers - Specialty & Generic

About Aurora Cannabis Inc.

Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through two segments, Canadian Cannabis and Plant Propagation. The company offers pharmaceutical-grade cannabis products; medical and consumer cannabis products; and engages in the propagation of vegetables and floral plants. It also provides dried and fresh … Full ACB analysis →

Key strengths

  • Cost Leadership Position Operating margin at 100.0th percentile with strong OpEx control demonstrates cost leadership.
  • Revenue Growth Consistent Revenue growth volatility is low (stability score 0.77), suggesting sticky customer base.

Key risks

  • Commodity Pressure / Weak Differentiation Gross margin at 37.5th percentile with high volatility suggests weak pricing power or commoditized products.
  • Volatile Margins Suggest Cyclicality Margin volatility is high (stability score 0.33), suggesting cyclical exposure or competitive pressure.

The dashed ring is the peer median. Defense scores are percentile ranks against peers, so 50 is roughly the typical company in this group.

Upgrade to unlock the signals and evidence behind each defense.

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power

Moderate
55
Premium

Signals, strengths and risks for Pricing Power

Premium

Signals, strengths and risks for Cost Advantage

Premium

Signals, strengths and risks for Customer Stickiness

Premium

Signals, strengths and risks for Capital Efficiency

Premium

Signals, strengths and risks for Resilience

Premium

Signals, strengths and risks for Scale & Market Position

Where ACB ranks in Drug Manufacturers - Specialty & Generic

Aurora Cannabis Inc. ranks #27 of 91 scored companies in Drug Manufacturers - Specialty & Generic by moat score — the top 30%. The widest moat in the group is Zoetis Inc. (ZTS) at 85/100.

# Company Moat score Rating
23 Pacira BioSciences, Inc. PCRX 62/100 Moderate
24 Harrow, Inc. HROW 61/100 Moderate
25 Takeda Pharmaceutical Company L TAK 59/100 Moderate
26 Elanco Animal Health Incorporat ELAN 58/100 Moderate
27 Aurora Cannabis Inc. ACB 58/100 Moderate
28 Alvotech ALVO 56/100 Moderate
29 Alvotech Warrant ALVOW 56/100 Moderate
30 Supernus Pharmaceuticals, Inc. SUPN 55/100 Moderate
31 Anika Therapeutics Inc. ANIK 54/100 Moderate

See every Pharma / Mature Biotech company ranked by moat score →

How ACB scores on the Corporate Default defenses

Pricing Power

Score 55 · 20% of the moat score

Pricing power is the ability to raise prices without losing volume.

Cost Advantage

Score 70 · 15% of the moat score

A cost advantage means delivering the same product for structurally less — better purchasing, denser distribution, a more automated process.

Customer Stickiness

Score 56 · 15% of the moat score

Stickiness is what makes revenue repeat without being re-won every year.

Capital Efficiency

Score 35 · 18% of the moat score

Capital efficiency asks what the company earns on the money tied up in the business.

Resilience

Score 62 · 17% of the moat score

Resilience is the capacity to get through a bad year on its own terms — enough liquidity, enough interest cover, and enough cash generation to avoid a rescue financing or a forced sale.

Scale & Market Position

Score 74 · 15% of the moat score

Scale matters only when it converts into economics.

How each Corporate Default defense is measured, in full →

Understanding ACB's moat

What is Aurora Cannabis Inc.'s moat score?

Aurora Cannabis Inc. (ACB) scores 58 out of 100 on the StatsAlpha Moat Map, which rates its competitive advantage as moderate. It ranks #27 of 91 scored companies in Drug Manufacturers - Specialty & Generic, the top 30%. The score is a weighted composite of 6 competitive defenses, each measured against industry peers of 90 companies in Drug Manufacturers - Specialty & Generic. Its strongest defense is Scale & Market Position (74/100) and its weakest is Capital Efficiency (35/100).

How does Aurora Cannabis Inc. compare with other Drug Manufacturers - Specialty & Generic companies?

Aurora Cannabis Inc. ranks #27 of 91 scored companies in Drug Manufacturers - Specialty & Generic by moat score. The widest moat in Drug Manufacturers - Specialty & Generic is Zoetis Inc. (ZTS) at 85/100. The companies ranked closest are Elanco Animal Health Incorporat (ELAN) at 58 just above it and Alvotech (ALVO) at 56 just below it.

How is the moat score calculated?

Each company is scored with an industry-specific template — Corporate Default in this case, chosen because the defenses that matter to a bank are not the ones that matter to a software company. Every defense combines several financial signals, and each signal is measured as a percentile against a peer group of 90 companies in Drug Manufacturers - Specialty & Generic. The defenses are then weighted to produce the overall score out of 100.

Why is Aurora Cannabis Inc. scored with the Corporate Default template?

Most public companies sell a product or a service at a margin, so the moat question is whether that margin survives contact with competitors. The Corporate template scores the six defenses that show up in a general operating company's financial signature: whether it can hold price, produce more cheaply than rivals, keep its customers, earn a return above its cost of capital, withstand a downturn, and turn size into economics.

Which competitive defenses are measured for Aurora Cannabis Inc.?

The Corporate Default template measures 6 defenses, and ACB scores: Pricing Power (55), Cost Advantage (70), Customer Stickiness (56), Capital Efficiency (35), Resilience (62), Scale & Market Position (74). Each is scored independently as a percentile against peers, so a company can be strong on one and weak on another — the overall score reflects how those defenses are weighted for this industry.

Send Feedback
Please select a category.
0/1000